These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23414367)
1. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. Yang YP; Qu JH; Chang XJ; Lu YY; Bai WL; Dong Z; Wang H; An LJ; Xu ZX; Wang CP; Zeng Z; Hu KQ J Transl Med; 2013 Feb; 11():41. PubMed ID: 23414367 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma]. Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. Qu JH; Chang XJ; Lu YY; Bai WL; Chen Y; Zhou L; Zeng Z; Wang CP; An LJ; Hao LY; Xu GL; Gao XD; Lou M; Lv JY; Yang YP World J Gastroenterol; 2012 Jun; 18(23):2995-3003. PubMed ID: 22736924 [TBL] [Abstract][Full Text] [Related]
4. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. Qiu J; Huang P; Liu Q; Hong J; Li B; Lu C; Wang L; Wang J; Yuan Y J Transl Med; 2011 Sep; 9():166. PubMed ID: 21955323 [TBL] [Abstract][Full Text] [Related]
5. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. Xie C; Wu J; Yun J; Lai J; Yuan Y; Gao Z; Li M; Li J; Song L PLoS One; 2013; 8(5):e64235. PubMed ID: 23717574 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Gao J; Ding F; Liu Q; Yao Y Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575 [TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma]. Chang XJ; Lu YY; Bai WL; Chen Y; An LJ; Zhou L; Wang H; Wu Y; Liu Z; Lou M; Zeng Z; Su SH; Yang YP Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):759-63. PubMed ID: 22409849 [TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation. Zheng Z; Gao S; Yang Z; Xie H; Zhang C; Lin B; Wu L; Zheng S; Zhou L Int J Med Sci; 2014; 11(2):142-50. PubMed ID: 24465159 [TBL] [Abstract][Full Text] [Related]
9. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Gao S; Lin BY; Yang Z; Zheng ZY; Liu ZK; Wu LM; Xie HY; Zhou L; Zheng SS Int J Med Sci; 2014; 11(3):268-75. PubMed ID: 24516351 [TBL] [Abstract][Full Text] [Related]
10. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway. Yao Y; Dou C; Lu Z; Zheng X; Liu Q Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117 [TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Wang C; Wang H; Yang W; Hu K; Xie H; Hu KQ; Bai W; Dong Z; Lu Y; Zeng Z; Lou M; Wang H; Gao X; Chang X; An L; Qu J; Li J; Yang Y Hepatology; 2015 May; 61(5):1579-90. PubMed ID: 25284802 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. Rong G; Bai W; Dong Z; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Wang H; Gao X; Chang X; An L; Li H; Chen Y; Hu KQ; Yang Y PLoS One; 2015; 10(4):e0123065. PubMed ID: 25849963 [TBL] [Abstract][Full Text] [Related]
13. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway. Zhang YM; Wu QM; Chang LY; Liu JC Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698 [TBL] [Abstract][Full Text] [Related]
14. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976 [TBL] [Abstract][Full Text] [Related]
15. MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Ji D; Lu ZT; Li YQ; Liang ZY; Zhang PF; Li C; Zhang JL; Zheng X; Yao YM Asian Pac J Cancer Prev; 2014; 15(2):999-1003. PubMed ID: 24568531 [TBL] [Abstract][Full Text] [Related]
16. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma. Liu T; Chen J; Xiao S; Lei X Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039 [TBL] [Abstract][Full Text] [Related]
17. [Subcellular proteomic analysis of Tetrazanbigen on human hepatocellular carcinoma cell line QGY-7701]. Yuan YH; Yang XL; Li W; Zheng XH; Gu R; Yu Y Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):908-11. PubMed ID: 22525503 [TBL] [Abstract][Full Text] [Related]
18. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915 [TBL] [Abstract][Full Text] [Related]
19. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650 [TBL] [Abstract][Full Text] [Related]
20. Analysis of therapeutic effectiveness and prognostic factor on argon-helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma. Huang C; Zhuang W; Feng H; Guo H; Tang Y; Chen H; Huang Y J Cancer Res Ther; 2016 Dec; 12(Supplement):C148-C152. PubMed ID: 28230008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]